Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:Rat NADPH-cytochrome P450 reductase fusion protein

Protein Expression and Purification

Volumn 9, Issue 3, 1997, Pages 346-354

  Parikh, Asit ^a   Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031127850     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1997.0721     Document Type: Article

References (53)

1. Keeney D. S., Waterman M. R. Regulation of steroid hydroxylase gene expression: Importance to physiology and disease. Pharmacol. Ther. 58:1993;301-317.
2. Higashi Y., Hiromasa T., Tanae A., Miki T., Nakura J., Kondo T., Ohura T., Ogawa E., Nakayama K., Fujii-Kuriyama Y. Effects of individual mutations in the P-450 (C21) pseudogene on the P-450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J. Biochem. 109:1991;638-644.
3. Miller W. L., Morel Y. The molecular genetics of 21-hydroxylase deficiency. Annu. Rev. Genet. 23:1989;371-393.
4. White P. C., Dupont J., New M. I., Leiberman E., Hochberg Z., Rösler A. A mutation in CYP11Ba (Arg 448 - His) associated with steroid 11β-hydroxylase deficiency in Jews of Moroccan origin. J. Clin. Invest. 87:1991;1664-1667.
5. Smith R. L., Idle J. R., Mahgoub A. A., Sloan T. P., Lancaster R. Genetically determined defects of oxidation at carbon centres of drugs. Lancet. i:1978;943-944.
6. Woosley R. L., Chen Y., Freiman J. P., Gillis R. A. Mechanism of the cardiotoxic actions of terfenadine. J. Am. Med. Assoc. 269:1993;1532-1536.
7. Guengerich F. P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48:1988;2946-2954.
8. Guengerich F. P. Characterization of roles of human cytochrome P-450 enzymes in carcinogen metabolism. Asia Pacific J. Pharmacol. 5:1990;327-345.
9. Guengerich F. P. Metabolic activation of carcinogens. Pharmacol. Ther. 54:1992;17-61.
10. Shimada T., Yun C-H., Yamazaki H., Gautier J-C., Beaune P. H., Guengerich F. P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 41:1992;856-864.
11. Sakaki T., Oeda K., Yabusaki Y., Ohkawa H. Monooxygenase activity ofSaccharomyces cerevisiae. J. Biochem. 99:1986;741-749.
12. Guengerich F. P., Gillam E. M. J., Shimada T. New applications of bacterial systems to problems in toxicology. Crit. Rev. Toxicol. 26:1996;551-583.
13. Yamazaki H., Ueng Y-F., Shimada T., Guengerich F. P. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of iron-sulfur proteins and oxygen surrogates. Biochemistry. 34:1995;8380-8389.
14. Dong M-S., Yamazaki H., Guo Z., Guengerich F. P. Recombinant human cytochrome P450 1A2 and an N-terminal truncated form: Construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 327:1996;11-19.
15. Shet M. S., Fisher C. W., Arlotto M. P., Shackleton C. H. L., Holmans P. L., Martin-Wixtrom C. A., Saeki Y., Estabrook R. W. Purification and enzymatic properties of a recombinant fusion protein expressed inEscherichia coli. Arch. Biochem. Biophys. 311:1994;402-417.
16. C. W. Fisher, M. S. Shet, P. L. Holmans, R. W. Estabrook, 24-28 October, 1993, Expression of fusions between cytochrome P450 and cytochrome P450 reductase inE. coli in, 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology, 81, Lisbon, Portugal.
17. Shet M. S., Fisher C. W., Holmans P. L., Estabrook R. W. Human cytochrome P450 3A4: Enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. Proc. Natl. Acad. Sci. USA. 90:1993;11748-11752.
18. Chun Y-J., Shimada T., Guengerich F. P. Construction of a human cytochrome P450 1A1:rat NADPH-P450 reductase fusion protein cDNA, expression inEscherichia coli, Arch. Biochem. Biophys. 330:1996;48-58.
19. Ruettinger R. T., Wen L. P., Fulco A. J. Coding nucleotide, 5′ regulatory, and deduced amino acid sequences of P-450BM-3, a single peptide cytochrome P-450:NADPH-P-450 reductase fromBacillus megaterium. J. Biol. Chem. 264:1989;10987-10995.
20. White K. A., Marletta M. A. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry. 31:1992;6627-6631.
21. McMillan K., Bredt D. S., Hirsch D. J., Snyder S. H., Clark J. E., Masters B. S. S. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc. Natl. Acad. Sci. USA. 89:1992;11141-11145.
22. Murakami H., Yabusaki Y., Sakaki T., Shibata M., Ohkawa H. A genetically engineered P450 monooxygenase: Construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase. DNA. 6:1987;189-197.
23. Shibata M., Sakaki T., Yabusaki Y., Murakami H., Ohkawa H. Genetically engineered P450 monooxygenases: Construction of bovine P450c17/yeast reductase fused enzymes. DNA Cell Biol. 9:1990;27-36.
24. Sakaki T., Shibata M., Yabusaki Y., Murakami H., Ohkawa H. Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPH-cytochrome P450 reductase inSaccharomyces cerevisiae. DNA Cell Biol. 9:1990;603-614.
25. PA. Proc. Natl. Acad. Sci. USA. 86:1989;7696-7700.
26. Butler M. A., Lang N. P., Young J. F., Caporaso N. E., Vineis P., Hayes R. B., Teitel C. H., Massengill J. P., Lawsen M. F., Kadlubar F. F. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics. 2:1992;116-127.
27. Sesardic D., Boobis A. R., Edwards R. J., Davies D. S. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26:1988;363-372.
28. Conney A. H., Buening M. K., Pantuck E. J. Regulation of human drug metabolism by dietary factors. Environmental Chemicals, Enzyme Function and Human Disease. 1980;Excerpta Medica, Amsterdam. p. 147-167.
29. Kadlubar F. F., Butler M. A., Kaderlik K. R., Chou H. C., Lang N. P. Polymorphisms for aromatic amine metabolism in humans: Relevance for human carcinogenesis. Environ. Health Perspect. 98:1992;69-74.
30. 1. Mol. Carcinogen. 3:1990;5-8.
31. Glatt H. R., Pauly K., Wölfel C. Stable expression of heterologous cytochromes P450 in V79 cells: Mutagenicity studies with polycyclic aromatic hydrocarbons. Polycyclic Aromatic Compounds: Synthesis, Properties, Analytical Measurements, Occurrence and Biological Effects: Proceedings of the Thirteenth International Symposium on Polynuclear Aromatic Hydrocarbons. 1993;Gordon and Breach, New York. p. 1167-1174.
32. Fisher C. W., Caudle D. L., Martin-Wixtrom C., Quattrochi L. C., Tukey R. H., Waterman M. R., Estabrook R. W. High-level expression of functional cytochrome P450 1A2 inEscherichia coli. FASEB J. 6:1992;759-764.
33. Sandhu P., Guo Z., Baba T., Martin M. V., Tukey R. H., Guengerich F. P. Expression of modified human cytochrome P450 1A2 inEscherichia coli: Arch. Biochem. Biophys. 309:1994;168-177.
34. Sandhu P., Baba T., Guengerich F. P. Expression of modified cytochrome P450 2C10 (2C9) inEscherichia coli, Arch. Biochem. Biophys. 306:1993;443-450.
35. Shen A. L., Porter T. D., Wilson T. E., Kasper C. B. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J. Biol. Chem. 264:1989;7584-7589.
36. Gillam E. M. J., Baba T., Kim B-R., Ohmori S., Guengerich F. P. Expression of modified human cytochrome P450 3A4 inEscherichia coli. Arch. Biochem. Biophys. 305:1993;123-131.
37. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239:1964;2370-2378.
38. Yasukochi Y., Masters B. S. S. Some properties of a detergent-solubilized NADPH-cytochromec. J. Biol. Chem. 251:1976;5337-5344.
39. Guengerich F. P. Analysis and characterization of enzymes. Hayes A. W. Principles and Methods of Toxicology. 1994;1259-1313 Raven Press, New York.
40. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminatiing inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-6467.
41. 4. Nature. 227:1970;680-685.
42. Wray W., Boulikas T., Wray V. P., Hancock R. Silver staining of proteins in polyacrylamide gels. Anal. Biochem. 118:1981;197-203.
43. Burke M. D., Mayer R. T. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkylethers (alkoxyresorufins). Chem.-Biol. Interact. 45:1983;243-258.
44. Burke M. D., Mayer R. T. Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metab. Dispos. 3:1975;245-253.
45. Larrey D., Distlerath L. M., Dannan G. A., Wilkinson G. R., Guengerich F. P. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry. 23:1984;2787-2795.
46. Distlerath L. M., Reilly P. E. B., Martin M. V., Davis G. G., Wilkinson G. R., Guengerich F. P. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 260:1985;9057-9067.
47. Gillam E. M. J., Guo Z., Martin M. V., Jenkins C. M., Guengerich F. P. Expression of cytochrome P450 2D6 inEscherichia coli, Arch. Biochem. Biophys. 319:1995;540-550.
48. Porter T. D., Wilson T. E., Kasper C. B. Expression of a functional 78,000 dalton mammalian flavoprotein, NADPH-cytochrome P-450 oxidoreductase, inEscherichia coli. Arch. Biochem. Biophys. 254:1987;353-367.
49. Fisher C. W., Shet M. S., Martin-Wixtrom C., Estabrook R. W. High-level expression inEscherichia coli. Proc. Natl. Acad. Sci. USA. 89:1992;10817-10821.
50. Imaoka S., Imai Y., Shimada T., Funae Y. Role of phospholipids in reconstituted cytochrome P450 3A forms and mechanism of their activation of catalytic activity. Biochemistry. 31:1992;6063-6069.
51. Kaminsky L. S., Dunbar D., Guengerich F. P., Lee J. J. Detergents as probes of reconstituted rat liver cytochrome P-450 function. Biochemistry. 26:1987;1276-1283.
52. O'Haver T. C., Green G. L. Numerical error analysis of derivative spectrometry for the quantitative analysis of mixtures. Anal. Chem. 48:1976;312-318.
53. Omura T., Sato R. Isolation of cytochromes P-450 and P-420. Methods Enzymol. 10:1967;556-561.